NCT05555914

Brief Summary

A selective neural stimulation as the investigators propose allows to stimulate several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, 2 electrodes will be implanted above the elbow on the median, the ulnar and the radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk through minimally invasive surgery. Our main hypothesis is that multipolar neural electrical stimulation of the median and the ulnar nerve (flexion) and the radial nerve (extension) allows:

  • on the one hand, a selective, individualized motor activation (muscle by muscle)
  • on the other hand, a synergistic motor activation (association of several muscles) for the purpose of production of functional movements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

September 27, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

October 10, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 29, 2024

Status Verified

October 1, 2022

Enrollment Period

1.1 years

First QC Date

August 29, 2022

Last Update Submit

January 26, 2024

Conditions

Keywords

TetraplegiaNeural stimulation

Outcome Measures

Primary Outcomes (1)

  • Functional outcome: Number of successful trials (task completed) out of 5 trials with 5 preselected objects.

    The objective is to show that neural electrical stimulation allows the user to master the completion of each of pre-selected gripping tasks. The evaluation criteria is the number of successful trials (task completed) out of 5 trials with 5 preselected objects. For each object, a successful gripping task is a task completed in a duration \<180 sec.

    Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29

Secondary Outcomes (7)

  • Functional outcome

    Following surgery from Day12: Day12, Day15, Day17, Day22, Day26 and Day29

  • Strength

    Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29

  • Fatigue

    Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29

  • Self perception and psychological well being

    Baseline prior to surgery and following surgery: Day8, Day15, Day22, Day29

  • System Usability Scale

    Following surgery : Day8 and Day29

  • +2 more secondary outcomes

Study Arms (1)

Neurostimulation

EXPERIMENTAL

Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia

Other: Neurostimulation

Interventions

Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements

Neurostimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent signed
  • Patient affiliated to a social security (state medical aid excepted).
  • Neurological level ≥ C7 4.18 years old ≤ age ≤ 65 years old,
  • complete traumatic injury: defined by an A or B score on the AIS scale. (AIS A or - complete motor deficit under injury. This is an internationally agreed standard for describing spinal cord injury) 6.neurological stability (no change in muscle testing) \> 6 months, 7.post-injury duration \> 6 months 8.patients without active muscle resources for conventional tendon transfer surgery on the forearm and hand

You may not qualify if:

  • patient deprived of liberty (by judicial or administrative decision).
  • adult patient who is subject to a legal protection measure or unable to express consent
  • participation in another ongoing clinical trial
  • pregnant or breastfeeding women or women of childbearing age without effective contraception
  • spasticity and contractures in flexion or extension of the upper limbs of a destabilizing nature.
  • unstable epilepsy with a notion of a epileptic seizure that occurred within the previous 12 months.
  • unstable cardiovascular pathology (coronary heart disease, major hypertension, heart failure, etc.).
  • wearing a pacemaker or a spinal cord stimulator implant
  • dermatological problems contraindicating the application of surface electrodes.
  • body weight \>100 kg
  • psychiatric condition and/or history contraindicating participation in research
  • any contraindications to anesthesia and/or surgery
  • hypersensitivity to low molecular weight heparin (LMWH) or to any of the excipients of the specialty used
  • history of immune-mediated heparin-induced thrombocytopenia (HIT) within the last 100 days or presence of circulating antibodies
  • clinically significant active bleeding or a condition associated with a high risk of bleeding
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Center Bouffard-Vercelli USSAP

Perpignan, 66000, France

Location

Related Publications (1)

  • Fattal C, Teissier J, Geffrier A, Fonseca L, William L, Andreu D, Guiraud D, Azevedo-Coste C. Restoring Hand Functions in People with Tetraplegia through Multi-Contact, Fascicular, and Auto-Pilot Stimulation: A Proof-of-Concept Demonstration. J Neurotrauma. 2022 May;39(9-10):627-638. doi: 10.1089/neu.2021.0381. Epub 2022 Feb 2.

MeSH Terms

Conditions

Quadriplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Charles FATTAL, MD, PhD

    Centre Bouffard Vercelli - USSAP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2022

First Posted

September 27, 2022

Study Start

October 10, 2022

Primary Completion

November 30, 2023

Study Completion

December 31, 2023

Last Updated

January 29, 2024

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations